Responsive Image

 

 

Responsive Image

Red de salud mental

Líneas de investigación

Espacio colaborativo con atención primaria
Investigación biomédica
Lehenak: coordinación de la continuidad asistencial para el acceso de pacientes al recurso primeros episodios
Trastorno mental grave
Trastornos de la personalidad
Trastorno infanto-juvenil
Adicciones
Suicidio
Psicogeriatría y discapacidad intelectual
Psicofarmacología

Foto grupo

Actividades del grupo

El Grupo de Investigación en Salud Mental está integrado por profesionales de los distintos dispositivos que conforman la Red de Salud Mental de Bizkaia  (RSMB) y tiene como objetivo desarrollar y potenciar  la investigación en una serie de Líneas estratégicas en el área de la salud mental, que posibilite generar conocimiento, para mejorar la efectividad y eficiencia de los servicios que la Red presta y nos permita prepararnos ante los retos asistenciales que en un futuro deberemos abordar como organización sanitaria.

Cada línea de investigación planteada  cuenta con un responsable o referente y dentro de las mismas se pretende abordar todos aquellos aspectos que están relacionados con,  la atención sociosanitaria, epidemiología, promoción- prevención y la efectividad-eficiencia de los dispositivos e intervenciones en salud mental.

Proyectos activos:

Evaluación de la recuperación en la atención a las personas con Trastorno Mental Grave en la Red de Salud Mental de Bizkaia

Adecuación del uso de Citalopram y Escitalopram en residencias de ancianos a las dosis marcadas en ficha técnica

Plan integral de salud mental para la coordinación del trastorno mental común.

Vademécum psicofarmacológico para personas con discapacidades del desarrollo. Fichas informativas para familiares y tutores y elaboración de hojas informativas para los pacientes.

Identificación de las actividades de enfermería en la intervención de prevención de recaídas en personas con enfermedad crónica.

Estudio de la eficacia de la terapia cognitivo conductual en la disminución de los síntomas negativos, mejora de funcionalidad y disminución de la discapacidad en pacientes con esquizofrenia.

Polimorfismos en MicroARNs y genes de riesgo para esquizofrenia y trastorno bipolar. Relación con el diagnóstico y los fenotipos clínicos.

Coordinador/a del grupo



Miembros del grupo

  Francisco Javier Ballesteros Rodríguez
 
  Miguel Ángel Landabaso Vázquez
 
 
  Maider Sánchez Pérez
 
 
  María Irene Rodríguez Marañón
 
 
  Fernando González Serrano
 
 
  Maria José Zardoya Mateo
 
 
  Beatriz Corcostegui Santiago
 
 
  Jon García Ormaza
 
 
  María Aurora Arrue Ulles
 
  |   844746
  Maider Prieto Etxebeste
 
 
  Luis Pacheco Yáñez
 
 
  María Isabel Zamalloa Jauregui
 
  |   844746
  Eskarne Zallo Atxutegi
 
 
  Ainara Arnaiz Muñoz
 
 
  Leire Erkoreka González
 
 
  Manuel Hernanz Ruiz
 
 
  Virginia Guillen Cañas
 
  Patxi Gil López
 
 
  Ana María Fernández Cagigas
 
 
  Patricia Caballero Martínez
 
 
  Beatriz García Moratalla
 
 
  Juan Medrano Albeniz
 
 
  José Juan Uriarte Uriarte
 
 
  María Concepción Moreno Calvete
 
 
  María Teresa Moreno Calle
 
 
  Aranzazu Iribarren Corera
 
 
  Ane Sarasola Gandariasbeitia
 
 
  Elena Marín Díaz-Guardamino
 
 
  José Ignacio Landaluce Lauzurica
 
 
  Rodrigo Joaquín Oraa Gil
 
 
  Fernando Lázaro Perlado
 
 
  Olga Olivas Gallego
 
 
  Noemí Varela Gómez
 
 
  Nerea Durán Núñez
 
 
  María Ángeles Irastorza Abans
 
 
  Myrian García Ruiz
 
 
  Irati Armentia Marín
 
 
  Verónica Sanmartín Cuevas
 
 
  María Begoña Rueda Ruiz
 
 
  Nerea Jauregizar Albonigamayor
 
 
  Alicia Loureiro González
 
 
  Pedro Muñoz Domínguez
 
 
  Raúl Sancho Echevarria
 
  María Isabel Macías Romero
 
 

Publicaciones del grupo

Moreno Calvete MC, Uriarte JJ, Penas P. Evidence-based practice in mental health. Enferm Clin. 2022; 32(1): 66-67. DOI:10.1016/j.enfcli.2021.06.004.

Lertxundi U, Domingo Echaburu S, Brodin T, Medrano J, Orive G. The future of psychiatry should be One Health. Rev Environ Health. 2022. DOI:10.1515/reveh-2022-0019.

Pico N, Jung HR, Medrano J, Abayebas M, Kim DY, Hwang JH, et al. Climbing control of autonomous mobile robot with estimation of wheel slip and wheel-ground contact angle. J Mech Sci Technol. 2022; 36(2): 959-968. DOI:10.1007/s12206-022-0142-6.

Moreno Calvete MC, Uriarte JJ, Penas P. Evidence-based practice in mental health. Enferm Clin (Engl Ed). 2022; 32(1): 66-67. DOI:10.1016/j.enfcle.2021.06.003.

Illarregi U, Telleria J, Bilbao Aldaiturriaga N, Lopez E, Ballesteros J, Martin Guerrero I, et al. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review. Int J Oncol. 2022; 60(5). DOI:10.3892/ijo.2022.5348.

Catalan A, Aymerich C, Bilbao A, Pedruzo B, Pérez JL, Aranguren N, et al. Psychosis and Substance Abuse increase the COVID-19 mortality risk. Psychol Med. 2022: 1-9. DOI:10.1017/S0033291722000976.

Martinez E, Buesa I, Guillen V, Azkue JJ. Short-term improvements in the body schema can modulate pain perception in fibromyalgia syndrome. Clin Exp Rheumatol. 2022; 40(6): 1127-1135. DOI:10.55563/clinexprheumatol/2vn0uh.

Saez E, Erkoreka L, Moreno Calle T, Berjano B, Gonzalez Pinto A, Basterreche N, et al. Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature. World J Psychiatr. 2022; 12(7): 884-896. DOI:10.5498/wjp.v12.i7.884.

Arietaleanizbeaskoa MS, Pablo S, Sancho A, Martin X, Moreno C, Grandes G. Barriers and facilitators of the EfiKroniK exercise program for people with chronic diseases in Primary Care. Aten Primaria. 2022; 54(10). DOI:10.1016/j.aprim.2022.102456.

Tabernero E, Rodrigo T, Garros J, Altube L, Garay E, Medina J-F, et al. TB in the elderly: clinical features and outcomes. Int J Tuberc Lung Dis. 2022; 26(9): 842-849. DOI:10.5588/ijtld.22.0010.

Vega L, Ibarguengoitia O, Garcia C, Enjuanes M, Galindez Agirregoikoa E, Calvo I, et al. PREGNANCY PLANNING AND FOLLOW-UP IN MULTIDISCIPLINARY UNITS IMPROVES THE OUTCOMES IN WOMEN WITH INFLAMMATORY ARTHROPATHIES. Ann Rheum Dis. 2022; 81: 1260-1260. DOI:10.1136/annrheumdis-2022-eular.2135.

Inchausti L, Gorostiza I, Gonzalez Torres MA, Oraa R. Diagnostic stability in substance-induced psychosis. Rev Psiquiatr Salud Ment (Engl Ed). 2022. DOI:10.1016/j.rpsmen.2019.10.006.

Uriarte JJ, Penas P, Moreno Calvete MC, Gorbena S, Iglesias N, alvarez A, et al. Assessment of Recovery in Severe Mental Disorder: REE (Recovery Enhancing Environment) Normative Data, Cut-off Points and Assessment Criteria for Individual Cases. Rev Iberoam Diagn Eval-Aval P. 2022; 4(65): 115-123. DOI:10.21865/RIDEP65.4.09.

Moreno Calvete MC, Ballesteros Rodriguez FJ. Non-pharmacological strategies for self-directed and interpersonal violence in people with severe mental illness: a rapid overview of systematic reviews. Bmj Open. 2021; 11(1): 43576-43576. DOI:10.1136/bmjopen-2020-043576.

Escudero J, Munoz JL, Morera Herreras T, Hernandez R, Medrano J, Domingo Echaburu S et al. Antipsychotics as environmental pollutants: An underrated threat?. Sci Total Environ. 2021; 769: 144634-144634. DOI:10.1016/j.scitotenv.2020.144634.

Gonzalez Fraile E, Ballesteros J, Rueda J, Santos Zorrozua B, Sola I, McCleery J. Remotely delivered information, training and support for informal caregivers of people with dementia. Cochrane Database Syst Rev. 2021; 1(1): 6440-6440. DOI:10.1002/14651858.CD006440.pub3.

Arnaiz A, Zumarraga M, Erkoreka L, Olivas O, Arrue A, Zamalloa MI et al. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter. Schizophr Res. 2021; 228: 382-384. DOI:10.1016/j.schres.2021.01.012.

Lertxundi U, Domingo Echaburu S, Hernandez R, Medrano J, Orive G. Venlafaxine and desvenlafaxine to be included in the surface water Watch List. Aust N Z J Psychiatry. 2021; 55(11): 1112-1112. DOI:10.1177/0004867421998787.

Recio Barbero M, Segarra R, Zabala A, Gonzalez Fraile E, Gonzalez Pinto A, Ballesteros J. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms. Front Psychiatry. 2021; 12: 631589-631589. DOI:10.3389/fpsyt.2021.631589.

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 122-127

Penas P, Uriarte J, Gorbena S, Slade M, Moreno Calvete M, Iraurgi I. Discrepancy between experience and importance of recovery components in the symptomatic and recovery perceptions of peoplewith severe mental disorders. BMC Psychiatry. 2021; 21(1): 277-277. DOI:10.1186/s12888-021-03287-y.

Garcia Ribas G, Garcia Arcelay E, Montoya A, Maurino J, Ballesteros J. Quantifying Knowledge of Alzheimer's Disease: An Analysis of the Psychometric Properties of the Alzheimer's Disease Knowledge Scale. Neurol Ther. 2021; 10(1): 213-224. DOI:10.1007/s40120-021-00230-x.

Erkoreka L, Zamalloa I, Rodriguez S, Munoz P, Mendizabal I, Zamalloa MI et al. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder. Clin Psychol Psychother. 2021; 29(2): 501-511. DOI:10.1002/cpp.2640.

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. CLINICAL NOTE: Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 125-127

Saposnik G, Bueno Gil G, Sempere AP, Rodriguez Antiguedad A, del Rio B, Baz M et al. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol. Front Neurol. 2021; 12. DOI:10.3389/fneur.2021.675520.

Meca Lallana JE, Maurino J, Perez Miralles F, Forero L, Sepulveda M, Calles C et al. Quantifying the patients perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021; 16(7): 255317-255317. DOI:10.1371/journal.pone.0255317.

Erkoreka L, Zumarraga M, Arrue A, Zamalloa MI, Arnaiz A, Olivas O et al. Genetics of adult attachment: An updated review of the literature. World J Psychiatry. 2021; 11(9): 530-542. DOI:10.5498/wjp.v11.i9.530.

Pascual FS, Munoz A, Oraa R, Florez G, Notario P, Seijo P et al. Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study. Eur Addict Res. 2021; 28(2): 1-12. DOI:10.1159/000520091.

Argaluza J, Domingo Echaburu S, Orive G, Medrano J, Hernandez R, Lertxundi U. Environmental pollution with psychiatric drugs. World J Psychiatry. 2021; 11(10): 791-804. DOI:10.5498/wjp.v11.i10.791.

Muela A, Balluerka N, Sansinenea E, Machimbarrena JM, Garcia Ormaza J, Ibarretxe N et al. A Social-Emotional Learning Program for Suicide Prevention through Animal-Assisted Intervention. Animals. 2021; 11(12). DOI:10.3390/ani11123375.

Erkoreka L, Basterreche N, Olivas O, Arnaiz A, Zamalloa MI, Moreno Calle T et al. Plasma gamma-aminobutiric acid levels in schizophrenia patients: correlation with positive, negative and global impression symptom severity. Eur Neuropsychopharmacol. 2021; 53: 112-113. DOI:10.1016/j.euroneuro.2021.10.151.

Gallego OO, Basterreche N, Arnaiz A, Erkoreka L, Zamalloa MI, Moreno MT et al. Polymorphisms in dopamine d2 receptor gene are associated with obesity in antipsychotic treatment patients: no relationship with eating habits changes. Eur Neuropsychopharmacol. 2021; 53: 219-219. DOI:10.1016/j.euroneuro.2021.10.285.

Unzueta Larrinaga P, Ibarra Lecue I, Barrena Barbadillo R, Diez Alarcia R, Landabaso MA, Mendibil B et al. Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia. Eur Neuropsychopharmacol. 2021; 53: 666-667. DOI:10.1016/j.euroneuro.2021.10.763.

Arellano JJR, Zallo F, Gardenal E, Rodriguez Carrillo M, Ramirez Penas O, Arrue A et al. Generalized and concomitant astrocytic atrophy in sporadic and familiar Alzheimer's disease. Eur Neuropsychopharmacol. 2021; 53: 539-540. DOI:10.1016/j.euroneuro.2021.10.806.

Varela Barca L, Fernández Felix BM, Navas Elorza E, Mestres CA, Muñoz P, Cuerpo Caballero G, et al. Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis. Eur J Cardio-Thorac Surg. 2020; 57(4): 724-731. DOI:10.1093/ejcts/ezz328.

Inchausti L, Gorostiza I, Gonzalez Torres MA, Oraa R. Diagnostic stability in substance-induced psychosis. Rev Psiquiatr Salud Ment. 2020. DOI:10.1016/j.rpsm.2019.10.005.

Erkoreka L, Zamalloa I, Rodriguez S, Muñoz P, Catalan A, Arrue A, et al. Genetic modulation of facial emotion recognition in borderline personality disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020; 99: 109816-109816. DOI:10.1016/j.pnpbp.2019.109816.

Lertxundi U, Hernández R, Medrano J, Orive G. Drug pollution and pharmacotherapy in psychiatry: A "platypus" in the room. Eur Psychiat. 2020; 63(1). DOI:10.1192/j.eurpsy.2020.32.

Uriarte JJ, Penas P, Moreno Calvete MC, Ridgway P, Iraurgi I. Evidence of psychometric adequacy of the Spanish Adaptation of REE: Recovery Enhancing Environment. Actas Esp Psiquiatr. 2020; 48(2): 75-88

Meca Lallana J, Maurino J, Angel Hernandez Perez M, Sempere AP, Brieva L, Garcia Arcelay E, et al. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective. Neurol Ther. 2020; 9(1): 173-179. DOI:10.1007/s40120-020-00176-6.

Erkoreka L, Ozamiz Etxebarria N, Ruiz O, Ballesteros J. Assessment of Psychiatric Symptomatology in Bilingual Psychotic Patients: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020; 17(11). DOI:10.3390/ijerph17114137.

Rodriguez Sanchez JM, Setien Suero E, Suarez Pinilla P, Mayoral Van Son J, Vazquez Bourgon J, Gil Lopez P, et al. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort. Psychol Med. 2020; 52(4): 1-10. DOI:10.1017/S0033291720002408.

Penas P, Uriarte JJ, Gorbena S, Moreno Calvete MC, Ridgway P, Iraurgi I. Psychometric Adequacy of Recovery Enhancing Environment (REE) Measure: CHIME Framework as a Theory Base for a Recovery Measure. Front Psychiatry. 2020; 11: 595-595. DOI:10.3389/fpsyt.2020.00595.

Morentin B, Suarez Mier MP, Monzo A, Ballesteros J, Molina P, Lucena J. Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases. Rev Esp Cardiol (Engl Ed). 2020; 74(3): 225-232. DOI:10.1016/j.rec.2020.05.044.

Moreno Calvete MC, Ruiz Ibanez I, Uriarte JJ. Scoping review protocol on non-pharmacological interventions for interpersonal and self-directed violence in adults with severe mental illness. Bmj Open. 2020; 10(9): 37006-37006. DOI:10.1136/bmjopen-2020-037006.

Meca Lallana J, Hernandez Perez MA, Sempere AP, Ruiz LB, Garcia Arcelay E, Terzaghi M, et al. The patients' perspective in multiple sclerosis: the SymptoMScreen questionnaire correlates with clinical characteristics and clinician-assessed outcomes. Neurology. 2020; 94(15)

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Repeat episode of late-onset psychosis associated with efavirenz. Actas Esp Psiquiatr. 2020; 48(4)

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Repeat episode of late-onset psychosis associated with efavirenz. Actas Esp Psiquiatr. 2020; 48(4): 181-90

Perez M, Amayra I, Lazaro E, Garcia M, Martinez O, Caballero P, et al. Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis. PLoS One. 2020; 15(5). DOI:10.1371/journal.pone.0233349.

Arietaleanizbeaskoa MS, Sancho A, Olazabal I, Moreno C, Gil E, Garcia Alvarez A, et al. Effectiveness of physical exercise for people with chronic diseases: the EFIKRONIK study protocol for a hybrid, clinical and implementation randomized trial. BMC Fam Pract. 2020; 21(1): 227-227. DOI:10.1186/s12875-020-01298-4.

Viada C, Bouza C, Fors M, Frias A, Alvarez M, Garcia L, et al. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer. Qual Life Res. 2020; 29(12): 3441-3448. DOI:10.1007/s11136-020-02584-5.

Guillen V, Rueda JR, Lopez Argumedo M, Sola I, Ballesteros J. Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis. Arch Sex Behav. 2020; 49(8): 2963-2979. DOI:10.1007/s10508-020-01817-5.

Catalan A, Garcia L, Sanchez Alonso S, Gil P, Diaz Marsa M, Olivares JM, et al. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis. Early Interv Psychiatry. 2020; 15(6): 1584-1594. DOI:10.1111/eip.13098.

Erkoreka L, Zamalloa I, Munoz P, Rodriguez S, Arrue A, Zamalloa MI, et al. Genetic modulation and gene-environment interaction of attachment in cluster b personality disorders. Eur Psychiat. 2020; 63: 152-152

Erkoreka L, Zamalloa I, Munoz P, Rodriguez S, Arrue A, Zamalloa MI, et al. Impact of parental psychopathology in the attachment style of cluster b personality disorders. Eur Psychiat. 2020; 63: 202-203

Moreno Calvete MC. The risk factors of self-directed violence in severe mental illness. A scoping review. Eur Psychiat. 2020; 63: 569-569

Lertxundi U, Erezuma I, Hernandez R, Medrano J, Garcia M, Aguirre C. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance). Int Clin Psychopharmacol. 2019; 34(2): 89-92. DOI:10.1097/YIC.0000000000000247.

Penas P, Iraurgi I, Concepcion Moreno M, Uriarte JJ. How is evaluated mental health recovery?: A systematic review. Actas Esp Psiquiatr. 2019; 47(1): 23-32

Arrue A, Angel Gonzalez Torres M, Basterreche N, Arnaiz A, Olivas O, Isabel Zamalloa M, et al. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels. NEUROCHEM INT. 2019; 124: 152-161. DOI:10.1016/j.neuint.2019.01.004.

Lertxundi U, Hernandez R, Medrano J. The impact of the ambiguous definition of ``month'' on pharmacotherapy. Med Hypotheses. 2019; 129: 109258-109258. DOI:10.1016/j.mehy.2019.109258.

Ayesa Arriola R, Tordesillas Gutierrez D, Setien Suero E, Remon Gallo D, Garcia Gonzalez MC, Albacete A, et al. Verbal Memory and Voxel Based Morphometry in First Episode Non-Affective Psychosis: A Process Oriented Approach. Neuropsychology. 2019; 33(4): 568-580. DOI:10.1037/neu0000540.

Moreno Calvete MC, Gonzalez Fraile E, Uriarte JJ, Ruiz Ibanez I, Santos B, Ballesteros J. Which are the risk factors of violence in mental illness? A scoping review. Eur Psychiat. 2019; 56: 444-445

Garcia Alonso CR, Almeda N, Salinas Perez JA, Gutierrez Colosia MR, Uriarte JJ, Salvador Carulla L. A decision support system for assessing management interventions in a mental health ecosystem: The case of Bizkaia (Basque Country, Spain). PLoS One. 2019; 14(2). DOI:10.1371/journal.pone.0212179.

Morata L, Cobo J, Fernandez Sampedro M, Guisado Vasco P, Ruano E, Lora Tamayo J, et al. Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections. Antimicrob Agents Chemother. 2019; 63(5). DOI:10.1128/AAC.02280-18.

Munoz Garcia G, Sanchez Martinez de Luna MM, Eskubi Goienetxe I, Arrieta Echeita G, Perez Fernandez JL, Landaluce Lauzurica JI, et al. Design and implementation of an inter-institutional pilot project for the socio-sanitary-educational integration of children with complex chronic diseases and other special needs (EVAI: Integrated care assessment team). Int J Integr Care. 2019; 19(1). DOI:10.5334/ijic.s3451.

Gonzalez Serrano F, Basabe Homobono AE, Panera Uribe C, Garran Sabando E, Etxebarria Izaguirre I, Garcia Ruiz M, et al. Detection and psychotherapeutic treatment of perinatal depression. Int J Integr Care. 2019; 19(1). DOI:10.5334/ijic.s3112.

Uriarte JJ, Penas Moran P, Moreno Calvete C. Evaluation of the recovery model in the Bizkaia Mental Health Network. Int J Integr Care. 2019; 19(1). DOI:10.5334/ijic.s3395.

Javier Sanz Fuentenebro F, Uriarte JJ, Bonet Dalmau P, Molina Rodriguez V, Bernardo Arroyo M. Pattern of use of clozapine in Spain. Variability and under -prescription. Rev Psiquiatr Salud Ment. 2019; 12(3): 151-162. DOI:10.1016/j.rpsm.2018.02.005.

Arnaiz Munoz A, Olivas O, Erkoreka L, Gaton MA, Barreiro A, Rodriguez J, et al. Factors affecting the efficacy of adjunctive aripiprazole in risperidone- or paliperidone-induced hyperprolactinemia. Eur Neuropsychopharmacol. 2019; 29(6): 125-126. DOI:10.1016/j.euroneuro.2019.09.208.

Olazagoitia Garmendia A, Rodriguez J, Bilbao J, Castellanos Rubio A. An inflammation-related SNP in XPO1 5 ` UTR regulates protein amount by altering m6A mRNA methylation. Eur J Hum Genet. 2019; 27(1): 627-627

Recio Barbero M, Zabala A, Segarra R, Santos B, Ballesteros FJ. Cognitive enhancers in schizophrenia: A meta-analysis of Alpha-7 nicotinic acetylcholine receptor agonists for cognitive deficits and negative symptoms. Eur Neuropsychopharmacol. 2019; 29(6): 465-466. DOI:10.1016/j.euroneuro.2019.09.657.

Domingo Echaburu S, Lertxundi Etxebarria U, Hernandez Palacios R, Medrano Albeniz J. Comments on the Anticholinergic Burden Calculator Web Tool. Farm Hosp. 2019; 43(5): 168-169. DOI:10.7399/fh.11298.

Gallego OO, Arrue A, Arnaiz A, Basterreche N, Erkoreka L, Varela N, et al. Genetic variants associated with low dopaminergic activity relate to parameters included in the metabolic syndrome after treatment with antipsychotics. Eur Neuropsychopharmacol. 2019; 29: 154-155. DOI:10.1016/j.euroneuro.2019.09.244.

Martinez E, Guillen V, Buesa I, Azkue JJ. A Distorted Body Schema and Susceptibility to Experiencing Anomalous Somatosensory Sensations in Fibromyalgia Syndrome. Clin J Pain. 2019; 35(11): 887-893. DOI:10.1097/AJP.0000000000000754.

Meca Lallana V, Branas Pampillon M, Higueras Y, Candeliere Merlicco A, Aladro Benito Y, Rodriguez De la Fuente O, et al. Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5). Mult Scler J Exp Transl Clin. 2019; 5(4). DOI:10.1177/2055217319887987.

Ballesteros J, Martinez Gines ML, Garcia Dominguez JM, Forero L, Prefasi D, Maurino J, et al. Assessing Stigma in Multiple Sclerosis: Psychometric Properties of the Eight-Item Stigma Scale for Chronic Illness (SSCI-8). International Journal of MS Care. 2019; 21(5): 195-199. DOI:10.7224/1537-2073.2018-053.

Erkoreka L, Zumárraga M, Macías I, Angel Gonzalez Torres M. The COMT Val158Met polymorphism exerts a common influence on avoidant attachment and inhibited personality, with a pattern of positive heterosis. Psychiatry Res. 2018; 262: 345-347. DOI:10.1016/j.psychres.2017.07.053.

Peña J, Ibarretxe Bilbao N, Sánchez P, Uriarte JJ, Elizagarate E, Gutierrez M, et al. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J Psychiatr Res. 2018; 101: 21-27. DOI:10.1016/j.jpsychires.2018.03.002.

Lertxundi U, Hernandez R, San Miguel S, Corcostegui B, Prieto M, Gonzalez U, et al. The burden of constipation in psychiatric hospitals. Int J Psychiat Clin. 2018; 22(2): 143-150. DOI:10.1080/13651501.2017.1384023.

Lertxundi U, Hernandez R, Medrano J, Domingo Echaburu S, Garcia M, Aguirre C. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation?. Int Clin Psychopharmacol. 2018; 33(1): 56-58. DOI:10.1097/YIC.0000000000000194.

Chung Y, Salvador Carulla L, Salinas Pérez JA, Uriarte JJ, Iruin Sanz A, García Alonso CR. Use of the self-organising map network (SOMNet) as a decision support system for regional mental health planning. Health Res Policy Syst. 2018; 16(1): 35-35. DOI:10.1186/s12961-018-0308-y.

Sánchez M, Castiella A, Zapata E, Zubiaurre L, Pérez Yeboles J, Mendibil L, et al. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterol Hepatol. 2018; 41(5): 311-313. DOI:10.1016/j.gastrohep.2017.05.010.

Santos B, Gonzalez Fraile E, Zabala A, Guillen V, Rueda JR, Ballesteros J. Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia. J Psychopharmacol. 2018; 32(11): 1155-1166. DOI:10.1177/0269881118805496.

Lertxundi U, Hernandez R, Corcóstegui B, Ibarra O, Mentxaka G, Medrano J. Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia. Medicine (Baltimore). 2018; 97(44). DOI:10.1097/MD.0000000000012990.

Javier Sanz Fuentenebro F, Uriarte JJ, Bonet Dalmau P, Molina Rodriguez V, Lubeiro Juarez A, Bernardo Arroyo M. VARIABILITY AND UNDERUTILISATION OF CLOZAPINE IN SPAIN. Schizophr Bull. 2018; 44(1): 205-205. DOI:10.1093/schbul/sby016.504.

Trincado S, Gonzalez L, Uriarte O, Ruiz de Azua T, Peralta D, Montero G, et al. Vitamin D levels in inpatients. Eur Psychiat. 2018; 48: 490-490

Erkoreka L, Navarro B. Vulnerable narcissism is associated with severity of depressive symptoms in dysthymic patients. Psychiatry Res. 2017; 257: 265-269. DOI:10.1016/j.psychres.2017.07.061.

Basterreche N, Arrue A, Arnaiz A, Erkoreka L, Peralta D, Zumarraga M. Mania preceding pancreatic cancer. Actas Esp Psiquiatr. 2017; 45(1): 43-46

Arnaiz A, Zumarraga M, Olivas O, Arrue A, Gaton M, Erkoreka L, et al. Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphisms. Eur Neuropsychopharmacol. 2017; 27(4): 653-654. DOI:10.1016/S0924-977X(17)31223-3.

Bilbao A, Garcia Perez L, Retolaza Balsategui A, Mendezona Pena JI, Estebanez S, de la Torre Escalera PV, et al. PSYCHOMETRIC PROPERTIES OF THE EQ-5D-5L IN PATIENTS WITH MAJOR DEPRESSION DISORDER. Value Health. 2017; 20(9): 758-758. DOI:10.1016/j.jval.2017.08.2141.

Bilbao A, Garcia Perez M, Martin Fernandez J, Retolaza Balsategui A, Arrasate M, Sordo T, et al. MAPPING FROM THE BDI-II TO THE EQ-5D-5L QUESTIONNAIRE IN PATIENTS WITH MAJOR DEPRESSION DISORDER. Value Health. 2017; 20(9): 755-756

Penas P, Moreno MC, Uriarte JJ, Ridgway P, Iraurgi I. How is evaluated mental health recovery?. Eur Psychiat. 2017; 41: 199-199. DOI:10.1016/j.eurpsy.2017.01.2145.

Penas P, Uriarte JJ, Ridgway P, Moreno MC, Iraurgi I. Spanish adaptation of the recovery enhancing environments (REE) measure: Preliminary results. Eur Psychiat. 2017; 41: 199-199. DOI:10.1016/j.eurpsy.2017.01.2144.

 

 

 

 

Rodriguez-Sanchez JM, Ayesa-Arriola R, Perez-Iglesias R, Perianez JA, Martinez-Garcia O, Gomez-Ruiz E, et al. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study. Schizophr Res. 2013;150:121-8. FI:4,426(Q1).

Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, Roiz-Santianez R, Martinez-Garcia O, Sanchez-Moreno J, et al. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology. 2013;227:615-25. FI:3,988(Q1).

Ayesa-Arriola R, Perez-Iglesias R, Rodriguez-Sanchez JM, Pardo-Garcia G, Tabares-Seisdedos R, Ayuso-Mateos JL, et al. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;43:23-8. FI:4,025(Q1).

Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, Pardo-Garcia G, Tabares-Seisdedos Rl, et al. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study. Psychiatry Res. 2013;209:302-8. FI:2,682(Q2).

Davila W, Basterreche N, Arrue A, Zamalloa MI, Gordo E, Davila R, et al. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients. PLoS One. 2013; 8:e62900. FI:3,534(Q1).

Lertxundi U, Domingo-Echaburu S, Ruiz-Osante B, Hernandez R, Peral J, Medrano J. Comments on Duran et al.'s systematic review of anticholinergic risk scales. Eur J Clin Pharmacol. 2013;69:1729. FI:2,697(Q2).

Paya B, Rodriguez-Sanchez JM, Otero S, Munoz P, Castro-Fornieles J, Parellada M, et al. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophr Res. 2013;146:103-10. FI:4,426(Q1).

Torrecilla M, Fernández-Aedo I, Arrue A, Zumarraga M, Ugedo L. Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. Int J Neuropsychopharmacol. 2013;16:1093-104. FI:5,264(Q1).

 

Tesis del grupo

Autor/a: June Corcuera Tejada. Título: "Revisiones sistemáticas y meta-análisis en modelos animales para la investigación traslacional de patologías psiquiátricas". Director/a: Dr. Francisco Javier Ballesteros Rodriguez.

Autor/a: Leire Erkoreka González. Título: Análisis exploratorio de la influencia sobre dimensiones de personalidad de polimorfismos genéticos funcionales de la catecol-o-metiltransferasa, el transportador de serotonina y la monoamino oxidasa-A, y su interacción con variables ambientales adversas. Un estudio en pacientes con trastornos de la personalidad y controles sanos. Director/a: Dr. Miguel Ángel González Torres, Dra. Mercedes Zumárraga.

© 2022 IIS Biocruces Bizkaia